RAAS, ACE2 and COVID-19; a mechanistic review.
Saudi J Biol Sci
; 28(11): 6465-6470, 2021 Nov.
Article
em En
| MEDLINE
| ID: mdl-34305426
ACE1, angiotensin-converting enzyme 1; ACE2; ACE2, angiotensin-converting enzyme 2; ACEIs; ACEIs, angiotensin-converting enzyme inhibitors; AEC-II, alveolar epithelial type II cells; ARBs; ARBs, angiotensin receptor blockers; AT1R, angiotensin type 1 receptor; AT2R, angiotensin type 2 receptor; Ang 1-7, angiotensin 1-7; Ang 1-9, angiotensin 1-9; AngI, angiotensin I; AngII, angiotensin II; Angiotensin 17; Angiotensin II; COVID-19; COVID-19, coronavirus disease 2019; CVD, cardiovascular disease; ERK, extracellular signal-regulated kinase; ICU, intensive care unit; MAPK, mitogen-activated protein kinase; NLRP3, (NOD, LRR, and pyrin domain-containing protein 3); RAAS, renin-angiotensin-aldosterone system; TGF-ß, transforming growth factor-beta; miR-21, microRNA-21
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article